Open AccessClinical outcome of Montelukast Sodium in Children with Adenoid Hypertrophy
Author(s) -
S. A. Naqi,
Ahmed Hassan Ashfaq,
Mumtaz Ahmad Umar,
Jais Kumar Karmani,
Naveed Arshad
Publication year - 2021
Publication title -
pakistan journal of medical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.316
H-Index - 30
eISSN - 1682-024X
pISSN - 1681-715X
DOI - 10.12669/pjms.37.2.2670
Subject(s) - medicine , adenoid , adenoidectomy , tonsillectomy , placebo , adenoid hypertrophy , otorhinolaryngology , montelukast , randomized controlled trial , nasal congestion , anesthesia , surgery , pediatrics , nose , asthma , alternative medicine , pathology
Generally, the blockage of upper respiratory tract in children is seen with the hypertrophy of adenoids and tonsils. Normally for patients with adenoid hypertrophy (AH), Adenoidectomy with or without Tonsillectomy is carried out, however it has its own complications like haemorrhage and recurrence of adenoid tissue. Consequently, therapeutic approach has increased extraordinary consideration rather than surgical procedure. The inflammatory process proposed for AH has prompted the utilization of anti-inflammatory drugs to treat this issue. The objective of this study was to assess the impacts of Montelukast sodium in children with enlarged adenoids.